Conventional Versus Automated Measurement of Blood Pressure in the Office (The CAMBO Study)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

750 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine if the use of automated office blood pressure readings can improve management of systolic hypertension in routine clinical practice. Automated office SBP recordings in routine clinical practice using the BpTRU device will reflect more accurately the mean awake ambulatory systolic BP than will manual BP readings taken with conventional mercury sphygmomanometry. This should lead to improvements in the management of systolic hypertension with optimization of drug therapy in practices using the BpTRU device.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Using the Blood Pressure TRU in Clinical Settings: a Knowledge Translation Study

NCT01357226

Blood Pressure

COMPLETED

Where Should Automated Blood Pressures be Done in Primary Care Offices?

NCT01538004

Hypertension

WITHDRAWN

Zero to Five Automated Oscillometric Office Blood Pressure (AOBP) Measurement

NCT03732924

Hypertension Cardiovascular Diseases

COMPLETED NA

Mercury Versus Automated Blood Pressure Monitoring

NCT01753895

Healthy Volunteers

COMPLETED

Automatic and Conventional Methods of Hypertensive Patients Monitoring

NCT06929728

Primary Hypertension

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BpTRU

Intervention Type DEVICE

Conventional mercury sphygmomanometry

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Both treated and untreated patients with systolic hypertension under routine FP care
* For untreated patients, routine office SBP as measured by the patient's FP at the last routine office visit using a mercury device must have SBP ≥ 160 mmHg and DBP \<= 95 mmHg
* For patients already receiving antihypertensive therapy, the last routine office BP as measured by the patient's FP using mercury sphygmomanometry must be SBP ≥ 140 mmHg and DBP \<= 90 mmHg

Exclusion Criteria

* Presence of target organ damage such as MI, stroke, and serum creatinine twice normal
* Diabetes mellitus treated with insulin or oral hypoglycemic therapy
* Secondary hypertension
* Participation in another research study involving measurement of BP
* Patient's insistence on using self BP measurement outside of the study
* Any conditions or circumstances which might preclude the successful completion of the study

Eligible Sex

ALL

Accepts Healthy Volunteers

No